New cell line to tackle drug resistant cancer
The creation of a new 'super cell' that can stand firm against one of the newest types of cancer therapy could shed new light on how to treat patients if they become resistant to these drugs.
The creation of a new 'super cell' that can stand firm against one of the newest types of cancer therapy could shed new light on how to treat patients if they become resistant to these drugs.
In-PharmaTechnologist.com brings you an update of pharmaceutical patent litigations.
US researchers have developed a fast and inexpensive protein biomarker detection device that could simplify disease diagnosis and aid in following disease progression in drug trials.
The first steps in tightening the safety controls on the pharmaceutical ingredients imported to the US from China have been taken following months of negotiations between the regulatory bodies of the two countries.
Novozymes and Millipore are to supply animal-free cell culture supplements to the biopharmaceutical industry.